CTRI/2021/04/033255已完成不适用
Evaluation of Skin Safety of a test product for Primary Skin Irritation Using Skin Irritation Test (Patch Test in Humans)IS 4011:2018 Guidelines.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 28
- 试验地点
- 1
- 主要终点
- Evaluation of cutaneous tolerance by dermatological scoring of skin reactions using Draize scale
研究概览
简要总结
The test product, Mincipex (Minoxidil TopicalSolution USP 5% w/v) - B No.: 101DS101 was dermatologically tested and found tobe “Non-Irritant†based on IS 4011:2018, Methods of Test for safety evaluationof cosmetics - Third Revision.
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Investigator Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •Fitzpatrick skin type III to IV.
- •Having apparently healthy skin on test area.
- •Willingness to avoid intense UV exposure on test site (sun or artificial UV), during the course of the study.
排除标准
- •Pregnancy (by history) and lactating women.
- •Scars, excessive terminal hair or tattoo on the studied area.
- •Hypersensitivity, allergy antecedent (to any cosmetic product, raw material, hair dye).
结局指标
主要结局
Evaluation of cutaneous tolerance by dermatological scoring of skin reactions using Draize scale
时间窗: 48 hours
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
To test the safety of a test product in healthy human volunteers.CTRI/2022/01/039409CIPLA LTD50
已完成
不适用
To evaluate safety of a test product for skin irritationCTRI/2022/06/043046Cipla Ltd52
已完成
不适用
To evaluate safety of a test product for skin irritatioCTRI/2022/06/043046Cipla Ltd52
已完成
不适用
To test the safety of a test product in healthy human volunteers.CTRI/2022/01/039409CIPLA LTD52
已完成
不适用
To test the safety of 3 test products for skin irritationCTRI/2021/03/032023Sun Pharmaceutical Industries Ltd60